TCT-690 Safety and Clinical Efficacy of Sideguard® Stent for Treatment of Bifurcation Lesions: Interim Results from the European Sideguard® Bifurcation Registry Study

Data collected include Patient demographics, PCI procedure and clinical follow-up up to 1 yr. Clinical end point studied includes death, myocardial infarction (MI) and target lesion revascularisation (TLR).

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2012-10, Vol.60 (17), p.B201-B201
Hauptverfasser: Fath-Ordoubadi, Farzin, Hauptmann, Karl-Eugen, Latib, Azeem, Eccleshall, Simon, Menown, Ian, Egred, Mohaned, Spyrou, Nicos, Sivananthan, Mohan, Mamas, Mamas, Sastry, Sanjay, Iqbal, Javed, Witherow, Fraser, Grech, Ever, Mills, Joseph
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Data collected include Patient demographics, PCI procedure and clinical follow-up up to 1 yr. Clinical end point studied includes death, myocardial infarction (MI) and target lesion revascularisation (TLR).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2012.08.728